Research ArticleOriginal Research

Family Physicians' Perception of the New mRNA COVID-19 Vaccines

Samuel Ofei-Dodoo, Rick Kellerman and Taylor Russell
The Journal of the American Board of Family Medicine September 2021, 34 (5) 898-906; DOI: https://doi.org/10.3122/jabfm.2021.05.210052

References

  1. 1.↵
    World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. Available at: https://covid19.who.int/. Accessed December 15, 2020.
  2. 2.↵
    Centers for Disease Control and Prevention (CDC) Coronavirus 2019. Case of coronavirus (COVID-19) in the United States. Available at: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/cases-in-us.html. Accessed December 15, 2020.
  3. 3.↵
    1. Ofei-Dodoo S,
    2. Loo-Gross C,
    3. Kellerman R
    . Burnout, Depression, Anxiety, and Stress among family physicians in Kansas responding to the COVID-19 pandemic. J Am Board Fam Med. 2021; May–Jun;34(3):522–530.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Stokes EK,
    2. Zambrano LD,
    3. Anderson KN,
    4. et al
    . Coronavirus Disease 2019 case surveillance — United States, January 22–May 30, 2020. MMWR Morb Mortal Wkly Rep 2020;69:759–65.
    OpenUrlCrossRefPubMed
  5. 5.↵
    United States Food and Drug Administration (FDA). Pfizer-BioNTech COVID-19 Vaccine. Available at: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine. Accessed December 15, 2020.
  6. 6.↵
    United States Food and Drug Administration (FDA). FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. Available at: https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid. Accessed December 18, 2020.
  7. 7.↵
    1. Omer SB,
    2. Salmon DA,
    3. Orenstein WA,
    4. DeHart MP,
    5. Halsey N
    . Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases. N Engl J Med 2009;360:1981–8.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Dubé E,
    2. Vivion M,
    3. Sauvageau C,
    4. Gagneur A,
    5. Gagnon R,
    6. Guay M
    . “Nature does things well, why should we interfere?”: vaccine hesitancy among mothers. Qual Health Res 2016;26:411–25.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Grandahl M,
    2. Oscarsson M,
    3. Stenhammar C,
    4. Nevéus T,
    5. Westerling R,
    6. Tydén T
    . Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccination. Acta Paediatr 2014;103:436–41.
    OpenUrl
  10. 10.↵
    1. Luthy KE,
    2. Beckstrand RL,
    3. Meyers CJ
    . Common perceptions of parents requesting personal exemption from vaccination. J Sch Nurs 2013;29:95–103.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Harmsen IA,
    2. Mollema L,
    3. Ruiter RA,
    4. Paulussen TG,
    5. de Melker HE,
    6. Kok G
    . Why parents refuse childhood vaccination: a qualitative study using online focus groups. BMC Public Health 2013;13:1183.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Kaiser Family Foundation. KFF COVID-19 Vaccine Monitor: December 2020. Available at: https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/. Accessed January 11, 2021.
  13. 13.↵
    1. Shen SC,
    2. Dubey V
    . Addressing vaccine hesitancy: clinical guidance for primary care physicians working with parents. Can Fam Physician 2019;65:175–81.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Chung Y,
    2. Schamel J,
    3. Fisher A,
    4. Frew PM
    . Influences on immunization decision-making among US parents of young children. Matern Child Health J 2017;21:2178–87.
    OpenUrlCrossRef
  15. 15.↵
    1. Freed GL,
    2. Clark SJ,
    3. Butchart AT,
    4. Singer DC,
    5. Davis MM
    . Sources and perceived credibility of vaccine-safety information for parents. Pediatrics 2011 May;127 Suppl 1:S107–12.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Tashakkori A,
    2. Teddlie C
    1. Creswell JW
    . Mapping the developing landscape of mixed methods research. In: Tashakkori A, Teddlie C (Eds.). Sage Handbook Of Mixed Methods in Social & Behavioral Research, 2nd ed. Thousand Oaks, CA: Sage; 2010: 45–68.
  17. 17.↵
    1. Dyrbye LN,
    2. West CP,
    3. Satele D,
    4. et al
    . Burnout among U.S. medical students, residents, and early career physicians relative to the general U.S. population. Acad Med 2014;89:443–51.
    OpenUrlCrossRefPubMed
  18. 18.↵
    American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. Available at: https://www.esomar.org/what-we-do/code-guidelines/AAPOR-Standard-Definitions-Final-Dispositions-of-Case-Codes-and-Outcome-Rates-for-Surveys. Accessed December 18, 2020.
  19. 19.↵
    1. Ofei-Dodoo S,
    2. Kellerman R,
    3. Gilchrist K,
    4. Casey EM
    . Burnout and Quality of Life among Active Member Physicians of the Medical Society of Sedgwick County. kjm 2019 May 15;12:33–9.
    OpenUrl
  20. 20.↵
    Statistics Kingdom. Chi-square Statistical power calculator. Available at: Available at: http://www.statskingdom.com/34test_power_chi2.html. Accessed December 18, 2020.
  21. 21.↵
    1. Kim HY
    . Statistical notes for clinical researchers: Chi-squared test and Fisher's exact test. Restor Dent Endod 2017;42:152–5.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Ofei-Dodoo S,
    2. Kellerman R,
    3. Nilsen K,
    4. Nutting R,
    5. Lewis D
    . Family physicians' perceptions of electronic cigarettes in tobacco use counseling. J Am Board Fam Med 2017;30:448–59.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Ofei-Dodoo S,
    2. Callaway P,
    3. Engels K
    . Prevalence and etiology of burnout in a community-based graduate medical education system: a mixed-methods study. Fam Med 2019;51:766–71.
    OpenUrl
  24. 24.↵
    1. Denzin NK,
    2. Lincoln YS
    1. Miller WL,
    2. Crabtree BF
    . Clinical Research. In: Denzin NK, Lincoln YS (Eds.). Handbook of Qualitative Research. Thousand Oaks, CA: Sage, 1994, pp. 340–52. ISBN: 1483349802.
  25. 25.↵
    1. Ofei-Dodoo S,
    2. Wipperman J,
    3. Nutting R,
    4. Gilchrist K,
    5. Kellerman R
    . Changes in family physicians' perceptions of electronic cigarettes in tobacco use counseling between 2016 and 2019. KJM 2020;13:311–7.
    OpenUrl
  26. 26.↵
    Data Star, Inc. What Every Researcher Should Know About Statistical Significance. 2008. Available at: http://www.surveystar.com/startips/oct2008.pdf. Accessed December 18, 2020.
  27. 27.↵
    1. Lin Y,
    2. Hu Z,
    3. Zhao Q,
    4. Alias H,
    5. Danaee M,
    6. Wong LP
    . Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis 2020;14:e0008961.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Schmid P,
    2. Rauber D,
    3. Betsch C,
    4. Lidolt G,
    5. Denker ML
    . Barriers of influenza vaccination intention and behavior - a systematic review of influenza vaccine hesitancy, 2005-2016. PLoS One 2017;12:e0170550.
    OpenUrlCrossRefPubMed
  29. 29.↵
    Mayo Clinic. COVID-19 vaccines: Get the facts. Available at: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-vaccine/art-20484859. Accessed January 8, 2021.
  30. 30.↵
    Centers for Disease Control and Prevention. Facts about COVID-19 Vaccines. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/facts.html. Accessed January 8, 2021.
  31. 31.↵
    1. Peiris M,
    2. Leung GM
    . What can we expect from first-generation COVID-19 vaccines? Lancet 2020;396:1467–9.
    OpenUrl
  32. 32.↵
    Centers for Disease Control and Prevention. Ensuring the Safety of COVID-19 Vaccines in the United States. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety.html. Accessed January 8, 2021.
  33. 33.↵
    1. Ng K,
    2. Poon BH,
    3. Kiat Puar TH,
    4. et al
    . COVID-19 and the risk to health care workers: a case report. Ann Intern Med 2020;172:766–7.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Walsh EE,
    2. Frenck RW Jr.,
    3. Falsey AR,
    4. et al
    . Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med 2020;383:2439–50.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Baden LR,
    2. El Sahly HM,
    3. Essink B,
    4. et al
    . Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. [published online ahead of print, 2020 Dec 30]. N Engl J Med 2021;384:403–16.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Oliver S,
    2. Gargano J,
    3. Marin M,
    4. et al
    . The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020. MMWR Morb Mortal Wkly Rep 2021;69:1653–6.
    OpenUrlCrossRef
  37. 37.↵
    Center for Disease Control and Prevention (CDC). Vaccination Considerations for People who are Pregnant or Breastfeeding. Available at: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html. Accessed January 8, 2021.
  38. 38.↵
    American College of Obstetrics and Gynecology. Vaccinating Pregnant and Lactating Patients Against COVID-19, December 2020. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/vaccinating-pregnant-and-lactating-patients-against-covid-19. Accessed January 8, 2021.
  39. 39.↵
    Society for Maternal-Fetal Medicine. Experts in High-Risk Pregnancy Respond to the FDA's Decision to Offer the Newly Approved COVID-19 Vaccine to Pregnant and Lactating People: Healthcare Workers Among the First Expected to Be Impacted. December 2020. Available at: https://s3.amazonaws.com/cdn.smfm.org/media/2632/FDA_final.pdf. Accessed January 8, 2021.
  40. 40.↵
    1. Dror AA,
    2. Eisenbach N,
    3. Taiber S,
    4. et al
    . Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol 2020;35:775–9.
    OpenUrlPubMed
  41. 41.↵
    1. Karlsson U,
    2. Fraenkel CJ
    . Covid-19: risks to healthcare workers and their families. BMJ 2020;371:m3944.
    OpenUrlFREE Full Text
  42. 42.↵
    1. Sim MR
    . The COVID-19 pandemic: major risks to healthcare and other workers on the front line. Occup Environ Med 2020;77:281–2.
    OpenUrlFREE Full Text
  43. 43.↵
    1. Roush SW,
    2. Murphy TV
    , Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298:2155–63.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    1. Pandolfi F,
    2. Franza L,
    3. Todi L,
    4. et al
    . The importance of complying with vaccination protocols in developed countries: “Anti-Vax” hysteria and the spread of severe preventable diseases. Curr Med Chem 2018;25:6070–81.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords